2E2B

Crystal structure of the c-Abl kinase domain in complex with INNO-406

Summary for 2E2B

Entry DOI	10.2210/pdb2e2b/pdb
Descriptor	Proto-oncogene tyrosine-protein kinase ABL1, N-[3-(4,5'-BIPYRIMIDIN-2-YLAMINO)-4-METHYLPHENYL]-4-{[(3S)-3-(DIMETHYLAMINO)PYRROLIDIN-1-YL]METHYL}-3-(TRIFLUOROMETHYL) BENZAMIDE (3 entities in total)
Functional Keywords	c-abl, kinase, inno-406, transferase
Biological source	Homo sapiens (human)
Cellular location	Cytoplasm, cytoskeleton. Isoform IB: Nucleus membrane; Lipid-anchor: P00519
Total number of polymer chains	2
Total formula weight	68632.25
Authors	Horio, T.,Hamasaki, T.,Wakayama, T.,Takagaki, K.,Ohgi, T. (deposition date: 2006-11-10, release date: 2007-05-22, Last modification date: 2023-10-25)
Primary citation	Horio, T.,Hamasaki, T.,Inoue, T.,Wakayama, T.,Itou, S.,Naito, H.,Asaki, T.,Hayase, H.,Niwa, T. Structural factors contributing to the Abl/Lyn dual inhibitory activity of 3-substituted benzamide derivatives Bioorg.Med.Chem.Lett., 17:2712-2717, 2007 Cited by PubMed: 17376680 DOI: 10.1016/j.bmcl.2007.03.002 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (2.2 Å)

Structure validation